TESARO and Medison Enter Into Exclusive Distribution Agreement to Commercialize ZEJULA® in Israel

NEXT STORY
ContraFect to Present CF-301 Data at the 28th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)
PREV STORY
Treos Bio Announces Activation of U.S. Clinical Trial Site for Phase 1 Study of PolyPEPI™ Precision Cancer Vaccine for Patients with Metastatic Colorectal Cancer
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Madrigal Pharmaceuticals Announces Support of Fatty Liver Foundation’s Screening Fund to Improve Diagnosis and Staging of Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH)

author_avatar
NASDAQ Market News

Helsinn Provides Educational Grant for ESMO’s Preceptorship for Supportive and Palliative Care

Helsinn Provides Educational Grant for ESMO’s Preceptorship for Supportive and Palliative Care              Lugano, Switzerland, ...

author_avatar
NASDAQ Market News

Translate Bio Expands Patent Portfolio with Newly Issued U.S. Patent Relating to Its Messenger RNA (mRNA) Therapeutics Platform (MRT™)

Patent Supports Foundational Intellectual Property and Pioneering Work in Liver Delivery for mRNA TherapeuticsLEXINGTON, ...

author_avatar
NASDAQ Market News